
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study
Mary A. De Vera, Monira Rahman, Vidula Bhole, et al.
Annals of the Rheumatic Diseases (2010) Vol. 69, Iss. 6, pp. 1162-1164
Open Access | Times Cited: 146
Mary A. De Vera, Monira Rahman, Vidula Bhole, et al.
Annals of the Rheumatic Diseases (2010) Vol. 69, Iss. 6, pp. 1162-1164
Open Access | Times Cited: 146
Showing 51-75 of 146 citing articles:
Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
Robert L. Jackson, Barbara Hunt, Patricia MacDonald
BMC Geriatrics (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Robert L. Jackson, Barbara Hunt, Patricia MacDonald
BMC Geriatrics (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Cardiovascular Risk Factors and Comorbidities in Patients with Hyperuricemia and/or Gout: A Systematic Review of the Literature
Caroline van Durme, I. A. A. M. van Echteld, Louise Falzon, et al.
Journal of Rheumatology Supplement (2014) Vol. 92, pp. 9-14
Closed Access | Times Cited: 39
Caroline van Durme, I. A. A. M. van Echteld, Louise Falzon, et al.
Journal of Rheumatology Supplement (2014) Vol. 92, pp. 9-14
Closed Access | Times Cited: 39
Langfassung zur S2e-Leitlinie Gichtarthritis (fachärztlich)
Uta Kiltz, Rieke Alten, Martin Fleck, et al.
Zeitschrift für Rheumatologie (2016) Vol. 75, Iss. S2, pp. 11-60
Closed Access | Times Cited: 38
Uta Kiltz, Rieke Alten, Martin Fleck, et al.
Zeitschrift für Rheumatologie (2016) Vol. 75, Iss. S2, pp. 11-60
Closed Access | Times Cited: 38
Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study
Jasvinder A. Singh, Rekha Ramachandaran, Shaohua Yu, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 37
Jasvinder A. Singh, Rekha Ramachandaran, Shaohua Yu, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 37
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?
Jasvinder A. Singh
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 4, pp. 631-634
Open Access | Times Cited: 34
Jasvinder A. Singh
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 4, pp. 631-634
Open Access | Times Cited: 34
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage
Alessandro Maloberti, Esmerilda Qualliu, Lucia Occhi, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 31, Iss. 1, pp. 178-185
Closed Access | Times Cited: 30
Alessandro Maloberti, Esmerilda Qualliu, Lucia Occhi, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 31, Iss. 1, pp. 178-185
Closed Access | Times Cited: 30
The Effects of GLUT9 and URAT1 Inhibitors on Cardiovascular Diseases: A Drug-Targeted Mendelian Randomization Study
Qian Xu, Xinyu Liang, Wei Shi, et al.
Research Square (Research Square) (2025)
Closed Access
Qian Xu, Xinyu Liang, Wei Shi, et al.
Research Square (Research Square) (2025)
Closed Access
Elevated risk of mortality among gout patients: A comparison with the National Population in Taiwan
Chang‐Fu Kuo, Kuang‐Hui Yu, Lai‐Chu See, et al.
Joint Bone Spine (2011) Vol. 78, Iss. 6, pp. 577-580
Closed Access | Times Cited: 35
Chang‐Fu Kuo, Kuang‐Hui Yu, Lai‐Chu See, et al.
Joint Bone Spine (2011) Vol. 78, Iss. 6, pp. 577-580
Closed Access | Times Cited: 35
Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in Taiwan
Victor C. Kok, Jorng Tzong Horng, Hsin-Li Lin, et al.
BMC Cardiovascular Disorders (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Victor C. Kok, Jorng Tzong Horng, Hsin-Li Lin, et al.
BMC Cardiovascular Disorders (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Consensus on patients with hyperuricemia and high cardiovascular risk treatment
И Е Чазова, Yu. V. Zhernakova, O. A. Kisliak, et al.
Systemic Hypertension (2019) Vol. 16, Iss. 4, pp. 8-21
Open Access | Times Cited: 24
И Е Чазова, Yu. V. Zhernakova, O. A. Kisliak, et al.
Systemic Hypertension (2019) Vol. 16, Iss. 4, pp. 8-21
Open Access | Times Cited: 24
Consensus on patients with hyperuricemia and high cardiovascular risk treatment: 2022
И Е Чазова, Yu. V. Zhernakova, O. A. Kislyak, et al.
Systemic Hypertension (2022) Vol. 19, Iss. 1, pp. 5-22
Open Access | Times Cited: 13
И Е Чазова, Yu. V. Zhernakova, O. A. Kislyak, et al.
Systemic Hypertension (2022) Vol. 19, Iss. 1, pp. 5-22
Open Access | Times Cited: 13
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
Alvin F. Wells, Patricia MacDonald, Solomon Chefo, et al.
BMC Musculoskeletal Disorders (2012) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Alvin F. Wells, Patricia MacDonald, Solomon Chefo, et al.
BMC Musculoskeletal Disorders (2012) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Gout treatment: should we aim for rapid crystal dissolution?
Eliseo Pascual, Mariano Andrés, Paloma Vela
Annals of the Rheumatic Diseases (2013) Vol. 72, Iss. 5, pp. 635-637
Closed Access | Times Cited: 26
Eliseo Pascual, Mariano Andrés, Paloma Vela
Annals of the Rheumatic Diseases (2013) Vol. 72, Iss. 5, pp. 635-637
Closed Access | Times Cited: 26
Gender interaction of uric acid in the development of hypertension
Shinichiro Nishio, Yukio Maruyama, Naoki Sugano, et al.
Clinical and Experimental Hypertension (2017) Vol. 40, Iss. 5, pp. 446-451
Closed Access | Times Cited: 24
Shinichiro Nishio, Yukio Maruyama, Naoki Sugano, et al.
Clinical and Experimental Hypertension (2017) Vol. 40, Iss. 5, pp. 446-451
Closed Access | Times Cited: 24
Disease‐Triggered Drug Release Effectively Prevents Acute Inflammatory Flare‐Ups, Achieving Reduced Dosing
Alexandra Stubelius, Wangzhong Sheng, Sang Eun Lee, et al.
Small (2018) Vol. 14, Iss. 32
Open Access | Times Cited: 21
Alexandra Stubelius, Wangzhong Sheng, Sang Eun Lee, et al.
Small (2018) Vol. 14, Iss. 32
Open Access | Times Cited: 21
The major cardiovascular events of febuxostat versus allopurinol in treating gout or asymptomatic hyperuricemia: a systematic review and meta-analysis
Meijiao Wang, Yi Zhang, Min Zhang, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 10, pp. 10327-10337
Open Access | Times Cited: 18
Meijiao Wang, Yi Zhang, Min Zhang, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 10, pp. 10327-10337
Open Access | Times Cited: 18
Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2023 update
Claudio Borghi, Justyna Domienik‐Karłowicz, Andrzej Tykarski, et al.
Cardiology Journal (2023) Vol. 31, Iss. 1, pp. 1-14
Open Access | Times Cited: 7
Claudio Borghi, Justyna Domienik‐Karłowicz, Andrzej Tykarski, et al.
Cardiology Journal (2023) Vol. 31, Iss. 1, pp. 1-14
Open Access | Times Cited: 7
Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case-control study
Hyung Woo Kim, Minjin Kang, Hyunsun Lim, et al.
Lara D. Veeken (2024)
Closed Access | Times Cited: 2
Hyung Woo Kim, Minjin Kang, Hyunsun Lim, et al.
Lara D. Veeken (2024)
Closed Access | Times Cited: 2
Management of Gouty Arthritis in Patients With Chronic Kidney Disease
Abdul Abdellatif, Naser Elkhalili
American Journal of Therapeutics (2012) Vol. 21, Iss. 6, pp. 523-534
Closed Access | Times Cited: 23
Abdul Abdellatif, Naser Elkhalili
American Journal of Therapeutics (2012) Vol. 21, Iss. 6, pp. 523-534
Closed Access | Times Cited: 23
Update on gout 2012
Alexander So, Nathalie Busso
Joint Bone Spine (2012) Vol. 79, Iss. 6, pp. 539-543
Closed Access | Times Cited: 21
Alexander So, Nathalie Busso
Joint Bone Spine (2012) Vol. 79, Iss. 6, pp. 539-543
Closed Access | Times Cited: 21
Gout and the Heart
Vidula Bhole, Eswar Krishnan
Rheumatic Disease Clinics of North America (2013) Vol. 40, Iss. 1, pp. 125-143
Closed Access | Times Cited: 21
Vidula Bhole, Eswar Krishnan
Rheumatic Disease Clinics of North America (2013) Vol. 40, Iss. 1, pp. 125-143
Closed Access | Times Cited: 21
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
М. С. Елисеев, A. M. Novikova
Terapevticheskii arkhiv (2019) Vol. 91, Iss. 5, pp. 120-128
Open Access | Times Cited: 18
М. С. Елисеев, A. M. Novikova
Terapevticheskii arkhiv (2019) Vol. 91, Iss. 5, pp. 120-128
Open Access | Times Cited: 18
Is serum uric acid a risk factor for atherosclerotic cardiovascular disease?
Boris Mankovsky, Ramaz Kurashvili, Shaukat Sadikot
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2010) Vol. 4, Iss. 3, pp. 176-184
Closed Access | Times Cited: 20
Boris Mankovsky, Ramaz Kurashvili, Shaukat Sadikot
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2010) Vol. 4, Iss. 3, pp. 176-184
Closed Access | Times Cited: 20
Inferring disease association using clinical factors in a combinatorial manner and their use in drug repositioning
Jin‐Myung Jung, Doheon Lee
Bioinformatics (2013) Vol. 29, Iss. 16, pp. 2017-2023
Open Access | Times Cited: 18
Jin‐Myung Jung, Doheon Lee
Bioinformatics (2013) Vol. 29, Iss. 16, pp. 2017-2023
Open Access | Times Cited: 18